As for possible mediators, the activating phosphorylation of separate and combined ERK1/2 was similar between TAC and control animals (Figure 2C), whereas that of AMPKα tended to be lower in TAC (p = 0.16) (Figure 2D). The gene discussed is MAPK3; the disease is persistent truncus arteriosus.